Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125480141 | 12548014 | 1 | I | 20160705 | 20160712 | 20160712 | EXP | CA-BAUSCH-BL-2016-016022 | BAUSCH AND LOMB | 0.00 | F | Y | 0.00000 | 20160712 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125480141 | 12548014 | 1 | PS | WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 1 | Oral | U | 21515 | 150 | MG | TABLET | BID | ||||||
| 125480141 | 12548014 | 2 | SS | ACETAMINOPHEN AND CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Oral | U | 86024 | 2 | DF | TABLET | TID | ||||||
| 125480141 | 12548014 | 3 | SS | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | U | 0 | .5 | MG | TABLET | TID | ||||||
| 125480141 | 12548014 | 4 | SS | CIPRALEX | ESCITALOPRAM OXALATE | 1 | Oral | U | 0 | 20 | MG | TABLET | |||||||
| 125480141 | 12548014 | 5 | SS | CO TEMAZEPAM | TEMAZEPAM | 1 | Oral | U | 0 | 30 | MG | CAPSULE | QD | ||||||
| 125480141 | 12548014 | 6 | SS | DOMPERIDONE | DOMPERIDONE | 1 | Unknown | U | 0 | 10 | MG | TABLET | BID | ||||||
| 125480141 | 12548014 | 7 | SS | FERROUS SULFATE. | FERROUS SULFATE | 1 | Unknown | U | 0 | 300 | MG | TID | |||||||
| 125480141 | 12548014 | 8 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | U | 0 | 300 | MG | CAPSULE | QD | ||||||
| 125480141 | 12548014 | 9 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | U | 0 | 600 | MG | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125480141 | 12548014 | 1 | Product used for unknown indication |
| 125480141 | 12548014 | 2 | Product used for unknown indication |
| 125480141 | 12548014 | 3 | Product used for unknown indication |
| 125480141 | 12548014 | 4 | Product used for unknown indication |
| 125480141 | 12548014 | 5 | Product used for unknown indication |
| 125480141 | 12548014 | 6 | Product used for unknown indication |
| 125480141 | 12548014 | 7 | Product used for unknown indication |
| 125480141 | 12548014 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125480141 | 12548014 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125480141 | 12548014 | Condition aggravated | |
| 125480141 | 12548014 | Dehydration | |
| 125480141 | 12548014 | Dysphagia | |
| 125480141 | 12548014 | Mental disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |